Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical decisions shall be required particularly in the 'difficult-to-treat' cases of high risk group with associated comorbidities. Convalescent...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transfus Apher Sci
Asıl Yazarlar: Çınar, Olgu Erkin, Sayınalp, Başak, Aladağ Karakulak, Elifcan, Avşar Karataş, Ayşe, Velet, Mustafa, İnkaya, Ahmet Çağkan, Ersoy Ortaç, Nazmiye Ebru, Öcal, Serpil, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Özcebe, Osman İlhami
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier Ltd. 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7258803/
https://ncbi.nlm.nih.gov/pubmed/32487513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2020.102821
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller